Pharmaceutical industry enterprises are setting off a wave of e-commerce, but after a wave of unrest, pharmaceutical companies have begun to rush to deploy mobile medical care : Xiaomi and Jiu'an work together to create a mobile health cloud platform, and Yuyue and Sequoia Capital march Internet Medical , Tomson Becker acquired Shenzhen Bitai to deploy mobile medical field.
The pharmacy has laid out e-commerce, and the industry still has various doubts. This road drug company has no idea what it is. Now how is this wave of cross-border mobile medical winds?
Doing mobile medical care is a bit reliable
"I think these pharmaceutical companies are first of all a concept of hype. Their mobile medical business has not made any progress, but the stock price has risen first." Xu Tianhong, a partner of the China Economic and Trade Joint Venture Group, bluntly pointed out that "these companies are not excluded." Long-term layout of mobile medical long-term considerations, the combination of conventional products and mobile medical, the front-end data collection and the back-end personal health management through, forming a closed loop, is a story that can be told, with industrial synergies, in theory, this business model is It is feasible. As long as it is a natural extension of the business, I don’t recommend it as a light consultation for Chunyu. It’s like a smart TV can be done by Changhong, but it’s not good to do Suning.â€
In fact, the combination of Jiu'an and Xiaomi has already made Jiu'an taste a little sweet. It is understood that Xiaomi's sales ability in wearable equipment is extremely strong. Before Jiu'an and Xiaomi jointly promoted the intelligent cloud sphygmomanometer of 199 yuan, and sold more than 10,000 units on Xiaomi's platform for two days, reflecting the amazing sales. The ability, this kind of sales ability can not even be reached by such large platforms as Jingdong and Tmall.
In addition, Jiu'an also tasted a sweetness that is bound to Xiaomi, the product adaptability and user experience have been greatly improved. Due to the unevenness of domestic mobile phones, it is extremely difficult for a wearable device to adapt to all platforms. Jiu'an was bound to Apple before, and now it has been attached to Xiaomi. The link with the mobile phone does not use the usual Bluetooth method, but takes the socket. In the form of this excellent user experience, other competitors look at it. That is to say, Jiu'an only cooperates with Xiaomi to achieve a perfect ride in the sales channel and user experience.
Tomson's entry into mobile medical care also has quite mature business considerations. Before Tomson Bianjian launched a network of 12 health management brands, 12 baskets consisted of nutrition products, dietitian services, mobile terminal systems (APP), smart scales, smart bracelets, and formed a mobile medical-based product. With service mode. Tomson Bianjian determined that the service should be carried by the mobile Internet, so it is reasonable to spend a lot of money to acquire relatively mature mobile medical products such as Shenzhen Bitei.
It should not be overlooked that the balance between online and offline is crucial for most traditional companies such as Tomson Bianjian, which sells online. A listed company can't give up its existing products and go to the main attack line. If you simply move the goods to the line or put the existing products on the line, then the blow to the offline channels is fatal, so online Operation must have a new business model, based on mobile health is an entry point.
Bi Lei, co-founder and vice president of Dr. Chun Yu, judged that the entry of pharmaceutical companies into mobile medical care will become a trend, because the business logic of pharmaceutical companies to enter mobile medical care is clear and feasible. "Mobile medical is essentially a new way of providing services. Pharmaceutical companies value mobile medical as a platform to retain users, may generate new users, or transfer offline users to the online, mobile medical users are very strong, Pharmaceutical companies then produce long-term commercial value by selling products on the platform. When the platform is built, these pharmaceutical companies have good products and strong liquidity. One user may consume 1,000 health products per year, 1 million users. It’s 10 billion sales, 10 million users is 10 billion!â€
The entry of pharmaceutical companies into mobile medical care is considered to be more reliable than e-commerce. The cost of obtaining electricity for e-commerce is relatively fixed, and the richer the SKU, the higher the conversion rate. However, the purpose of pharmaceutical companies to enter mobile medical care is to keep high-quality users on the platform. Selling products is a routine to break the money. It is to leave users with needs, push the corresponding products, and generate repeated purchases. Need so many SKUs. The core of mobile healthcare is users, and the core of e-commerce is traffic. These drugs have hundreds of millions of dollars in funds and they have found that because of their narrow product lines, the conversion rate is low, and the cost of acquiring users is quite high. Do mobile medical, they will find that they do not need to fight traffic, they sell diabetes products, only need to get diabetes users.
Herb extract we mainly supply are monk fruit extract, shiitake mushroom extract, reshi mushroom extract and other mushroom extract like lion`s mane extract. The main active ingredient among those powders are polysaccharides, beta glucan and so on. And monk fruit extract is one of our hot selling natural sweetener which can be added in very wide range of food and beverage. Unlike sugar, it is a kind of non- nutritive sweetener which is low in calories and high in sweetness, welcome to reach us for more information.
Herb Extract,Reishi Mushroom Extract,Mushroom Extract,Shiitake Mushroom Extract
YT(Xi'an) Biochem Co., Ltd. , https://www.ytherblifes.com